{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:03:57Z","timestamp":1792195437592,"version":"4.4.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.jaad.2009.08.052","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T10:37:37Z","timestamp":1273660657000},"page":"680-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: A review"],"prefix":"10.1016","volume":"63","author":[{"given":"Ngoc Quan","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.08.052_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrn1950","article-title":"The neurobiology of itch","volume":"7","author":"Ikoma","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jaad.2009.08.052_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejpain.2006.03.005","article-title":"Chronic itch and pain\u2013similarities and differences","volume":"10","author":"St\u00e4nder","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jaad.2009.08.052_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1345\/aph.10121","article-title":"Opioid antagonists in the treatment of opioid-induced constipation and pruritus","volume":"35","author":"Friedman","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2009.08.052_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000542-197605000-00008","article-title":"Pharmacokinetics of naloxone in rats and man","volume":"44","author":"Ngai","year":"1976","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaad.2009.08.052_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0022-3565(25)27721-7","article-title":"The human pharmacology and abuse potential of n-allylnoroxymorphone (Naloxone)","volume":"157","author":"Jasinski","year":"1967","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2009.08.052_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1973.01750360022003","article-title":"Naltrexone, an antagonist for the treatment of heroin dependence","volume":"28","author":"Martin","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaad.2009.08.052_bib7","first-page":"1207","article-title":"Duration of occupancy of opiate receptors by naltrexone","volume":"29","author":"Lee","year":"1988","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jaad.2009.08.052_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2165\/00003495-198835030-00002","article-title":"Naltrexone: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence","volume":"35","author":"Gonzalez","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2009.08.052_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cpt1976203315","article-title":"Naltrexone: disposition, metabolism and effects after acute and chronic dosing","volume":"20","author":"Verebey","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2009.08.052_bib10","first-page":"15","article-title":"Bioequivalence, dose proportionality and pharmacokinetics of naltrexone after oral administration","volume":"45","author":"Meyer","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jaad.2009.08.052_bib11","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0090-9556(25)05648-X","article-title":"The urinary excretion profile of naltrexone and metabolites in man","volume":"2","author":"Cone","year":"1974","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaad.2009.08.052_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4684-3503-0_17","article-title":"Hormonal and other effects of naltrexone in normal men","volume":"116","author":"Volavka","year":"1979","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaad.2009.08.052_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/jm00237a008","article-title":"Narcotic antagonist, 4carbon-6 derivates of Nsubstituted noroxymorphones as narcotic antagonists","volume":"18","author":"Hahn","year":"1975","journal-title":"J Med Chem"},{"key":"10.1016\/j.jaad.2009.08.052_bib14","first-page":"1726","article-title":"Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by dual-detector systems","volume":"38","author":"Kim","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jaad.2009.08.052_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/clpt.1986.220","article-title":"Prolonged blockade of opioid effect with oral nalmefene","volume":"40","author":"Gal","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2009.08.052_bib16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/j.1552-4604.1996.tb04179.x","article-title":"The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene","volume":"36","author":"Matzke","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2009.08.052_bib17","first-page":"175","article-title":"Binding of a new opiate antagonist, nalmefene, to rat brain membranes","volume":"7","author":"Michel","year":"1985","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.jaad.2009.08.052_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00006565-199904000-00016","article-title":"Nalmefene hydrochloride","volume":"15","author":"Chumpa","year":"1999","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.jaad.2009.08.052_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/j.1552-4604.1987.tb02191.x","article-title":"Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist","volume":"27","author":"Dixon","year":"1987","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2009.08.052_bib20","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2009.08.052_bib22","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.510270307","article-title":"Open label trial of oral nalmefene therapy for the pruritus of cholestasis","volume":"27","author":"Bergasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jaad.2009.08.052_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0016-5085(00)70225-3","article-title":"Florid opioid withdrawal-like reactions precipitated by naltrexone in a patient with chronic cholestasis","volume":"118","author":"Jones","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2009.08.052_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0190-9622(89)80353-6","article-title":"Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis","volume":"21","author":"Monroe","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1681\/ASN.V113514","article-title":"Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study","volume":"11","author":"Pauli-Magnus","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2009.08.052_bib26","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","article-title":"Randomized crossover trial of naltrexone in uremic pruritus","volume":"348","author":"Peer","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2009.08.052_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1440-0960.1997.tb01696.x","article-title":"Naltrexone: a case report of pruritus from an antipruritic","volume":"38","author":"Sullivan","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s002130000666","article-title":"Adverse effects of oral naltrexone: analysis of data from two clinical trials","volume":"154","author":"Oncken","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jaad.2009.08.052_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2230.1988.tb00744.x","article-title":"Opiates, sleep and itch","volume":"13","author":"Burch","year":"1988","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib30","first-page":"1022","article-title":"Pilot study of the use of naltrexone to treat the severe pruritus of cholestatic liver disease","volume":"91","author":"Carson","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.08.052_bib31","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00042737-200111000-00022","article-title":"Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy","volume":"13","author":"Neuberger","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/clpt.1985.197","article-title":"Effects of long-term therapy with naltrexone on body weight in obesity","volume":"38","author":"Atkinson","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2009.08.052_bib33","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(86)91196-7","article-title":"Naltrexone and hepatotoxicity","volume":"1","author":"Mitchell","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2009.08.052_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0009-9236(97)90178-8","article-title":"Effects of liver disease on the disposition of the opioid antagonist nalmefene","volume":"61","author":"Frye","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2009.08.052_bib35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s003930170004","article-title":"Peripheral analgesic and antiinflammatory effects of opioids","volume":"60","author":"Stein","year":"2001","journal-title":"Z Rheumatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1749-6632.2000.tb05440.x","article-title":"The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in normal and skin-grafted mice","volume":"917","author":"Sacerdote","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2009.08.052_bib37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1165\/rcmb.2006-0327OC","article-title":"Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation","volume":"37","author":"Singleton","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaad.2009.08.052_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0168-8278(97)80355-8","article-title":"Effect of liver cirrhosis on the systemic availability of naltrexone in humans","volume":"27","author":"Bertolotti","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0190-9622(81)80079-5","article-title":"Butorphanol-induced pruritus antagonized by naloxone","volume":"5","author":"Bernstein","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00510355","article-title":"Potentiation of histamine-induced itch and flare response in human skin by the enkephalin analogue FK 33-824, beta-endorphin and morphine","volume":"274","author":"Fjellner","year":"1982","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2009.08.052_bib41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00000542-200003000-00023","article-title":"An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception","volume":"92","author":"Ko","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaad.2009.08.052_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(99)00958-1","article-title":"Evidence that N-terminal fragments of nociceptin modulate nociceptin-induced scratching, biting and licking in mice","volume":"279","author":"Sakurada","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jaad.2009.08.052_bib43","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/bmj.284.6321.1015","article-title":"Intraspinal opiates and itching: a new reflex?","volume":"284","author":"Scott","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2009.08.052_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/82924","article-title":"Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch","volume":"4","author":"Andrew","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jaad.2009.08.052_bib45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archderm.1979.04010110058029","article-title":"Relief of intractable pruritus with naloxone","volume":"115","author":"Bernstein","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/1523-1747.ep12497974","article-title":"Antipruritic effect of an opioid antagonist, naloxone hydrochloride","volume":"78","author":"Bernstein","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(97)00098-5","article-title":"Opiate and H1 antagonist effects on histamine induced pruritus and allokinesis","volume":"73","author":"Heyer","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.jaad.2009.08.052_bib48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2125.1980.tb01742.x","article-title":"Naloxone modulates the perception of itch in man","volume":"10","author":"Summerfield","year":"1980","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2009.08.052_bib49","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0022-3565(24)37703-1","article-title":"Substance P induction of itch associated response mediated by cutaneous NK1 tachykinin receptors in mice","volume":"286","author":"Andoh","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2009.08.052_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-0102(99)00070-X","article-title":"Itch-associated response induced by intradermal serotonin through 5-HT2 receptors in mice","volume":"35","author":"Yamaguchi","year":"1999","journal-title":"Neurosci Res"},{"key":"10.1016\/j.jaad.2009.08.052_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1346-8138.1999.tb03516.x","article-title":"Recent studies of cutaneous nociception in atopic and nonatopic subjects","volume":"26","author":"Heyer","year":"1999","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib52","first-page":"355","article-title":"Naloxone in the treatment of uremic pruritus: a case history","volume":"21","author":"Andersen","year":"1984","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jaad.2009.08.052_bib53","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000077841","article-title":"A comparative study on the effects of naltrexone and loratadine on uremic pruritus","volume":"208","author":"Legroux-Crespel","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2009.08.052_bib54","first-page":"64","article-title":"Naltrexone in the treatment of renal itch","volume":"139","author":"Ghura","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib55","first-page":"641","article-title":"Naloxone versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus","volume":"82","author":"Kendrick","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaad.2009.08.052_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF03020347","article-title":"Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine","volume":"35","author":"Penning","year":"1988","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jaad.2009.08.052_bib57","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00003643-200010000-00004","article-title":"Itching after intrathecal morphine Incidence and treatment","volume":"17","author":"Slappendel","year":"2000","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jaad.2009.08.052_bib58","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3565(25)20595-X","article-title":"Neurochemical and functional correlates of naltrexone-induced opiate receptor upregulation","volume":"232","author":"Tempel","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2009.08.052_bib59","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2005.12.010","article-title":"Butorphanol for treatment of intractable pruritus","volume":"54","author":"Dawn","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib60","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00105-004-0802-8","article-title":"Antipruritic therapy with the oral opioid receptor antagonist naltrexone: open, non-placebo controlled administration in 133 patients","volume":"55","author":"Brune","year":"2004","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2009.08.052_bib61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0190-9622(99)70117-9","article-title":"Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study","volume":"41","author":"Bergasa","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib62","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2009.08.052_bib63","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0016-5085(92)90102-5","article-title":"A controlled trial of naloxone infusions for the pruritus of chronic cholestasis","volume":"102","author":"Bergasa","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaad.2009.08.052_bib64","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1001\/jama.1992.03490230089034","article-title":"The pruritus of cholestasis and the opioid system","volume":"268","author":"Jones","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2009.08.052_bib65","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2009.08.052_bib66","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(02)00318-5","article-title":"Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo controlled study","volume":"37","author":"Terg","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib67","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v12.i7.1125","article-title":"Effect of oral naltrexone on pruritus in cholestatic patients","volume":"12","author":"Mansour-Ghanaei","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2009.08.052_bib68","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1525-1470.2008.00699.x","article-title":"The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case","volume":"25","author":"Chang","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib69","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-97-5-788_3","article-title":"Naloxone, itch, asthma, urticaria and angioedema","volume":"97","author":"Smitz","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2009.08.052_bib70","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0091-6749(88)90571-4","article-title":"Controlled antipruritic trial of nalmefene in chronic urticaria and atopic dermatitis","volume":"81","author":"Banerji","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2009.08.052_bib71","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1034\/j.1600-0625.2002.110508.x","article-title":"Efficacy of naltrexone on acetylcholine-induced allokinesis in atopic eczema","volume":"11","author":"Heyer","year":"2002","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2009.08.052_bib72","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.burns.2007.10.009","article-title":"Naltrexone for the management of post-burn pruritus: a preliminary report","volume":"23","author":"LaSalle","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2009.08.052_bib73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/120347540500900502","article-title":"Successful treatment of refractory aquagenic pruritus with naltrexone","volume":"9","author":"Ingber","year":"2005","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2009.08.052_bib74","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1681\/ASN.2005020152","article-title":"Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies","volume":"16","author":"Wikstr\u00f6m","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jaad.2009.08.052_bib75","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4065\/83.10.1116","article-title":"Development of peripheral opioid antagonists' new insights into opioid effects","volume":"83","author":"Moss","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2009.08.052_bib76","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0376-8716(98)00087-8","article-title":"Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine","volume":"52","author":"Yuan","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jaad.2009.08.052_bib77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1254\/jphs.CRJ05001X","article-title":"Butorphanol: effects of a prototypical agonist-antagonist analgesic on\u00a0kappa-opioid receptors","volume":"98","author":"Commiskey","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jaad.2009.08.052_bib78","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/01.anes.0000278876.20263.a7","article-title":"Effects of butorphanol on morphine-induced itch and analgesia in primates","volume":"107","author":"Lee","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaad.2009.08.052_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0885-3924(96)00154-6","article-title":"Transnasal butorphanol for the treatment of opioid-induced pruritus unresponsive to antihistamines","volume":"12","author":"Dunteman","year":"1996","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jaad.2009.08.052_bib80","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11938-004-0009-1","article-title":"Treatment of the pruritus of cholestasis","volume":"7","author":"Bergasa","year":"2004","journal-title":"Curr Treat Options Gastroenterol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209012080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209012080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:16:29Z","timestamp":1759270589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209012080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0190962209012080"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.08.052","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipruritic treatment with systemic \u03bc-opioid receptor antagonists: A review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}